Shakiba Houshi
YOU?
Author Swipe
View article: Treatment-resistant Inflammatory Demyelinating Pseudotumor with Marburg-Like Features: A Rare Case Report
Treatment-resistant Inflammatory Demyelinating Pseudotumor with Marburg-Like Features: A Rare Case Report Open
Inflammatory demyelinating pseudotumors (IDPs), also known as tumor-like demyelinating lesions, are rare conditions that mimic intracranial neoplasms, presenting significant diagnostic challenges. The Marburg variant of multiple sclerosis …
View article: Association between comorbidities and health-related quality of life in patients with multiple sclerosis
Association between comorbidities and health-related quality of life in patients with multiple sclerosis Open
View article: Long-Term Adverse Events of Rituximab in Multiple Sclerosis Patients, Isfahan, Iran
Long-Term Adverse Events of Rituximab in Multiple Sclerosis Patients, Isfahan, Iran Open
Background: This study’s objective was to assess the adverse events (AEs) of rituximab (RTX) therapy in people with multiple sclerosis (pwMS). Methods: This observational study was conducted on clinical data of pwMS who visited an MS cente…
View article: Treatment-resistant inflammatory demyelinating pseudotumor with Marburg-like features: A narrative review-based treatment approach
Treatment-resistant inflammatory demyelinating pseudotumor with Marburg-like features: A narrative review-based treatment approach Open
Inflammatory demyelinating pseudotumor (IDP) mimics intracranial neoplasms in terms of both clinical presentation and imaging features. IDP with Marburg-like features represents a severe form of inflammatory demyelinating encephalomyelitis…
View article: Demographic and Clinical Characteristics of Familial and Sporadic Multiple Sclerosis Patients
Demographic and Clinical Characteristics of Familial and Sporadic Multiple Sclerosis Patients Open
Background: Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating, immune-mediated disease of the central nervous system. It is still unestablished whether heredity correlates with the disease's progression and severity. Method…
View article: Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis
Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis Open
Background. We conducted this study to assess the effect of disease-modifying therapies (DMTs) on coronavirus disease (COVID-19) susceptibility and severity in people with multiple sclerosis (MS). Methods. Available studies from PubMed, Sc…
View article: Factors associated with COVID-19 susceptibility and severity in patients with multiple sclerosis: A systematic review
Factors associated with COVID-19 susceptibility and severity in patients with multiple sclerosis: A systematic review Open
Background We conducted this systematic review to identify factors associated with coronavirus disease (COVID-19) susceptibility and outcomes among people with multiple sclerosis (MS). Methods Available studies from PubMed, Scopus, EMBASE,…